r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

CM

Cristian Massacesi

Insider · EVP,Chief Med Offr,Head of Dev · BMY

Cristian Massacesi files insider transactions with the SEC as an evp,chief med offr,head of dev of Bristol Myers Squibb Co. We hold 1 disclosed purchase or sale filed since 5 August 2025, 1 of them in the last 90 days.

  • Files forBMY
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure10 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 August 2025 — 9 September 2026EVP,Chief Med Offr,Head of Dev · Bristol Myers Squibb Co 9 Form 4 lines · source: SEC Form 4

Every transaction

9 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
9 of 9 shown
9 Sep 202610 Sep 2026SEC Form 41 dsold on the open marketBristol Myers Squibb Co6,249 sharesdown −1.2%down −0.2%
1 Aug 20264 Aug 2026SEC Form 43 dexercised options overnot a tradeBristol Myers Squibb Co51,172 sharesdown −2.6%down −3.4%
1 Aug 20264 Aug 2026SEC Form 43 dhad shares withheld for taxnot a tradeBristol Myers Squibb Co26,175 sharesdown −2.6%down −3.4%
1 Aug 20264 Aug 2026SEC Form 43 dexercised options overnot a tradeBristol Myers Squibb Coderivative51,172 sharesdown −2.6%down −3.4%
10 Mar 202612 Mar 2026SEC Form 42 dwas grantednot a tradeBristol Myers Squibb Coderivative26,122 sharesup +5.8%up +8.0%
10 Mar 202612 Mar 2026SEC Form 42 dwas grantednot a tradeBristol Myers Squibb Coderivative39,184 sharesup +5.8%up +8.0%
10 Mar 202612 Mar 2026SEC Form 42 dwas grantednot a tradeBristol Myers Squibb Coderivative26,122 sharesup +5.8%up +8.0%
10 Mar 202612 Mar 2026SEC Form 42 dwas grantednot a tradeBristol Myers Squibb Coderivative39,184 sharesup +5.8%up +8.0%
1 Aug 20255 Aug 2025SEC Form 44 dwas grantednot a tradeBristol Myers Squibb Coderivative204,691 sharesup +43.9%up +38.8%

Both percentages are the stock’s move, not Cristian Massacesi’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 9 of the 9 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.